HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China · Delayed Price · Currency is CNY 11.29
+0.18 (1.62%)
Feb 3, 2026, 3:00 PM CST
SHA:600829 Revenue
HPGC Renmintongtai Pharmaceutical had revenue of 2.70B CNY in the quarter ending September 30, 2025, with 0.15% growth. This brings the company's revenue in the last twelve months to 10.22B, down -0.26% year-over-year. In the year 2024, HPGC Renmintongtai Pharmaceutical had annual revenue of 10.05B, down -3.29%.
Revenue (ttm)
10.22B
Revenue Growth
-0.26%
P/S Ratio
0.64
Revenue / Employee
3.56M
Employees
2,870
Market Cap
6.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.05B | -341.70M | -3.29% |
| Dec 31, 2023 | 10.39B | 748.89M | 7.77% |
| Dec 31, 2022 | 9.64B | 325.86M | 3.50% |
| Dec 31, 2021 | 9.32B | 1.31B | 16.36% |
| Dec 31, 2020 | 8.01B | -348.62M | -4.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition